GlassScriptPhysician profile
Susan E Schorer
NPI 1770075574
$2,723.32
in general payments reported to CMS, 2019-2025
32 companies · $594 in 2025
The $594 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $679 · 2023: $818 · 2024: $632 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,044.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $866.00 | 2022-2025 | Interstim, Altaviva, Nuro |
| Myriad Genetic Laboratories, INC. | $195.47 | 2022-2025 | Prolaris, Myrisk |
| Abbvie INC. | $178.95 | 2023-2025 | |
| Janssen Biotech, INC. | $159.81 | 2022-2024 | Erleada, Akeega |
| Procept Biorobotics Corporation | $158.25 | 2022-2024 | Aquabeam System |
| Sumitomo Pharma America, INC. | $146.45 | 2023-2025 | Gemtesa, Orgovyx |
| Myovant Sciences INC. | $119.12 | 2022 | |
| Astellas Pharma US INC | $93.45 | 2022-2024 | Myrbetriq, Veozah |
| Astrazeneca Pharmaceuticals LP | $84.83 | 2022 | |
| Tolmar, INC. | $80.16 | 2023-2025 | Jatenzo, Eligard |
| Dendreon Pharmaceuticals LLC | $76.03 | 2022-2023 | Provenge |
| Boston Scientific Corporation | $74.56 | 2023-2024 | Rezum Generator, Lithovue |
| Endo Pharmaceuticals INC. | $67.71 | 2023 | Xiaflex, Aveed |
| Pfizer INC. | $52.66 | 2022-2024 | |
| Axonics, INC. | $44.29 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $36.84 | 2022 | |
| Blue Earth Diagnostics | $34.71 | 2022-2023 | |
| Urovant Sciences INC | $27.29 | 2022 | |
| Antares Pharma, INC. | $21.80 | 2023 | Nocdurna, Xyosted, Tlando |
| Abc Home Medical Supply, INC. | $21.47 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.38 | 2022 | |
| Convatec INC. | $18.90 | 2023 | |
| Merck Sharp & Dohme LLC | $18.40 | 2023 | Keytruda, Lynparza |
| Hollister Incorporated | $16.96 | 2023 | Vapro Pocket |
| Amgen INC. | $16.75 | 2022 | |
| Urogen Pharma, INC. | $13.59 | 2022 | |
| Photocure INC | $13.48 | 2024 | Cysview |
| Coloplast Corp | $13.42 | 2023 | Speedicath |
| Angiodynamics, INC. | $13.16 | 2024 | Nanoknife |
| Halozyme INC | $13.14 | 2023 | |
| Progenics Pharmaceuticals, INC. | $12.69 | 2023 | Pylarify |
| 180 Medical, INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Schorer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.